Signal pathways JNK and NF-κB, identified by global gene expression profiling, are involved in regulation of TNFα-induced mPGES-1 and COX-2 expression in gingival fibroblasts

BMC Genomics

Volumn 11, Issue 1, 2010, Pages

  Båge, Tove ^a   Lindberg, Johan ^b   Lundeberg, Joakim ^b   Modéer, Thomas ^a   Yucel Lindberg, Tülay ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b ROYAL INSTITUTE OF TECHNOLOGY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4 METHYLPHENYLSULFONYL) 2 PROPENENITRILE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; CYCLOOXYGENASE 2; ENZYME INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MICROSOME ENZYME; PROSTAGLANDIN E SYNTHASE; PROSTAGLANDIN E SYNTHASE 1; PROSTAGLANDIN E SYNTHASE 2; RO 106 9920; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ISOMERASE; NFKB1 PROTEIN, HUMAN;

ARTICLE; CONTROLLED STUDY; CYTOPLASM; DNA MICROARRAY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; FACTORIAL ANALYSIS; FIBROBLAST; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GINGIVA; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; MICROSOME; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING; METABOLISM;

CYCLOOXYGENASE 2; FIBROBLASTS; GENE EXPRESSION PROFILING; GINGIVA; HUMANS; INTRAMOLECULAR OXIDOREDUCTASES; NF-KAPPA B P50 SUBUNIT; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77950833537     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-11-241     Document Type: Article

References (91)

1. Bascones A, Noronha S, Gomez M, Mota P, Gonzalez Moles MA, Dorrego MV. Tissue destruction in periodontitis: bacteria or cytokines fault?. Quintessence Int 2005, 36:299-306.
2. Page RC, Offenbacher S, Schroeder HE, Seymour GJ, Kornman KS. Advances in the pathogenesis of periodontitis: summary of developments, clinical implications and future directions. Periodontol 2000 1997, 14:216-248. 10.1111/j.1600-0757.1997.tb00199.x, 9567973.
3. Pihlstrom BL, Michalowicz BS, Johnson NW. Periodontal diseases. Lancet 2005, 366:1809-1820. 10.1016/S0140-6736(05)67728-8, 16298220.
4. Yucel-Lindberg T, Nilsson S, Modeer T. Signal transduction pathways involved in the synergistic stimulation of prostaglandin production by interleukin-1beta and tumor necrosis factor alpha in human gingival fibroblasts. J Dent Res 1999, 78:61-68. 10.1177/00220345990780010901, 10065947.
5. Noguchi K, Ishikawa I. The roles of cyclooxygenase-2 and prostaglandin E2 in periodontal disease. Periodontol 2000 2007, 43:85-101. 10.1111/j.1600-0757.2006.00170.x, 17214837.
6. Dewhirst FE, Moss DE, Offenbacher S, Goodson JM. Levels of prostaglandin E2, thromboxane, and prostacyclin in periodontal tissues. J Periodontal Res 1983, 18:156-163. 10.1111/j.1600-0765.1983.tb00348.x, 6223995.
7. Preshaw PM, Heasman PA. Prostaglandin E2 concentrations in gingival crevicular fluid: observations in untreated chronic periodontitis. J Clin Periodontol 2002, 29:15-20. 10.1034/j.1600-051x.2002.290103.x, 11846844.
8. Saegusa M, Murakami M, Nakatani Y, Yamakawa K, Katagiri M, Matsuda K, Nakamura K, Kudo I, Kawaguchi H. Contribution of membrane-associated prostaglandin E2 synthase to bone resorption. J Cell Physiol 2003, 197:348-356. 10.1002/jcp.10356, 14566964.
9. Tsai CC, Hong YC, Chen CC, Wu YM. Measurement of prostaglandin E2 and leukotriene B4 in the gingival crevicular fluid. J Dent 1998, 26:97-103. 10.1016/S0300-5712(96)00084-X, 9540305.
10. Williams RC, Jeffcoat MK, Howell TH, Rolla A, Stubbs D, Teoh KW, Reddy MS, Goldhaber P. Altering the progression of human alveolar bone loss with the non-steroidal anti-inflammatory drug flurbiprofen. J Periodontol 1989, 60:485-490.
11. Jeffcoat MK, Page R, Reddy M, Wannawisute A, Waite P, Palcanis K, Cogen R, Williams RC, Basch C. Use of digital radiography to demonstrate the potential of naproxen as an adjunct in the treatment of rapidly progressive periodontitis. J Periodontal Res 1991, 26:415-421. 10.1111/j.1600-0765.1991.tb01731.x, 1832454.
12. Graves DT, Cochran D. The contribution of interleukin-1 and tumor necrosis factor to periodontal tissue destruction. J Periodontol 2003, 74:391-401. 10.1902/jop.2003.74.3.391, 12710761.
13. Assuma R, Oates T, Cochran D, Amar S, Graves DT. IL-1 and TNF antagonists inhibit the inflammatory response and bone loss in experimental periodontitis. J Immunol 1998, 160:403-409.
14. Gaspersic R, Stiblar-Martincic D, Osredkar J, Skaleric U. Influence of subcutaneous administration of recombinant TNF-alpha on ligature-induced periodontitis in rats. J Periodontal Res 2003, 38:198-203. 10.1034/j.1600-0765.2003.01395.x, 12608915.
15. Pers JO, Saraux A, Pierre R, Youinou P. Anti-TNF-alpha immunotherapy is associated with increased gingival inflammation without clinical attachment loss in subjects with rheumatoid arthritis. J Periodontol 2008, 79:1645-1651. 10.1902/jop.2008.070616, 18771364.
16. Rosenstein ED, Weissmann G, Greenwald RA. Porphyromonas gingivalis, periodontitis and rheumatoid arthritis. Med Hypotheses 2009, 73:457-458. 10.1016/j.mehy.2009.04.008, 19464122.
17. Soory M. Periodontal diseases and rheumatoid arthritis: a coincident model for therapeutic intervention?. Curr Drug Metab 2007, 8:750-757. 10.2174/138920007782798162, 18220555.
18. Gartlehner G, Hansen RA, Jonas BL, Thieda P, Lohr KN. The comparative efficacy and safety of biologics for the treatment of rheumatoid arthritis: a systematic review and metaanalysis. J Rheumatol 2006, 33:2398-2408.
19. Yucel-Lindberg T, Olsson T, Kawakami T. Signal pathways involved in the regulation of prostaglandin E synthase-1 in human gingival fibroblasts. Cell Signal 2006, 18:2131-2142. 10.1016/j.cellsig.2006.04.003, 16766159.
20. Bingham CO, Austen KF. Phospholipase A2 enzymes in eicosanoid generation. Proc Assoc Am Physicians 1999, 111:516-524. 10.1046/j.1525-1381.1999.99321.x, 10591080.
21. Needleman P. Characterization of the reaction sequence involved in phospholipid labeling and deacylation and prostaglandin synthesis and actions. J Allergy Clin Immunol 1978, 62:96-102. 10.1016/0091-6749(78)90085-4, 97337.
22. Smith WL, Song I. The enzymology of prostaglandin endoperoxide H synthases-1 and -2. Prostaglandins Other Lipid Mediat 2002, 68-69:115-128. 10.1016/S0090-6980(02)00025-4, 12432913.
23. Murakami M, Nakatani Y, Tanioka T, Kudo I. Prostaglandin E synthase. Prostaglandins Other Lipid Mediat 2002, 68-69:383-399. 10.1016/S0090-6980(02)00043-6, 12432931.
24. Park JY, Pillinger MH, Abramson SB. Prostaglandin E2 synthesis and secretion: the role of PGE2 synthases. Clin Immunol 2006, 119:229-240. 10.1016/j.clim.2006.01.016, 16540375.
25. Jakobsson PJ, Thoren S, Morgenstern R, Samuelsson B. Identification of human prostaglandin E synthase: a microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target. Proc Natl Acad Sci USA 1999, 96:7220-7225. 10.1073/pnas.96.13.7220, 22058, 10377395.
26. Tanikawa N, Ohmiya Y, Ohkubo H, Hashimoto K, Kangawa K, Kojima M, Ito S, Watanabe K. Identification and characterization of a novel type of membrane-associated prostaglandin E synthase. Biochem Biophys Res Commun 2002, 291:884-889. 10.1006/bbrc.2002.6531, 11866447.
27. Tanioka T, Nakatani Y, Semmyo N, Murakami M, Kudo I. Molecular identification of cytosolic prostaglandin E2 synthase that is functionally coupled with cyclooxygenase-1 in immediate prostaglandin E2 biosynthesis. J Biol Chem 2000, 275:32775-32782. 10.1074/jbc.M003504200, 10922363.
28. Watanabe K, Kurihara K, Tokunaga Y, Hayaishi O. Two types of microsomal prostaglandin E synthase: glutathione-dependent and -independent prostaglandin E synthases. Biochem Biophys Res Commun 1997, 235:148-152. 10.1006/bbrc.1997.6708, 9196052.
29. Watanabe K, Kurihara K, Suzuki T. Purification and characterization of membrane-bound prostaglandin E synthase from bovine heart. Biochim Biophys Acta 1999, 1439:406-414.
30. Bage T, Modeer T, Kawakami T, Quezada HC, Yucel-Lindberg T. Regulation of prostaglandin E synthases: effects of siRNA-mediated inhibition of microsomal prostaglandin E synthase-1. Biochim Biophys Acta 2007, 1773:1589-1598. 10.1016/j.bbamcr.2007.07.008, 17707523.
31. Yucel-Lindberg T, Hallstrom T, Kats A, Mustafa M, Modeer T. Induction of microsomal prostaglandin E synthase-1 in human gingival fibroblasts. Inflammation 2004, 28:89-95. 10.1023/B:IFLA.0000033024.13748.c1, 15379214.
32. Devaux Y, Seguin C, Grosjean S, de Talance N, Camaeti V, Burlet A, Zannad F, Meistelman C, Mertes PM, Longrois D. Lipopolysaccharide-induced increase of prostaglandin E(2) is mediated by inducible nitric oxide synthase activation of the constitutive cyclooxygenase and induction of membrane-associated prostaglandin E synthase. J Immunol 2001, 167:3962-3971.
33. Gudis K, Tatsuguchi A, Wada K, Futagami S, Nagata K, Hiratsuka T, Shinji Y, Miyake K, Tsukui T, Fukuda Y, Sakamoto C. Microsomal prostaglandin E synthase (mPGES)-1, mPGES-2 and cytosolic PGES expression in human gastritis and gastric ulcer tissue. Lab Invest 2005, 85:225-236. 10.1038/labinvest.3700200, 15531909.
34. Mustafa M, Wondimu B, Yucel-Lindberg T, Kats-Hallstrom AT, Jonsson AS, Modeer T. Triclosan reduces microsomal prostaglandin E synthase-1 expression in human gingival fibroblasts. J Clin Periodontol 2005, 32:6-11. 10.1111/j.1600-051X.2004.00622.x, 15642051.
35. Cheng S, Afif H, Martel-Pelletier J, Pelletier JP, Li X, Farrajota K, Lavigne M, Fahmi H. Activation of peroxisome proliferator-activated receptor gamma inhibits interleukin-1beta-induced membrane-associated prostaglandin E2 synthase-1 expression in human synovial fibroblasts by interfering with Egr-1. J Biol Chem 2004, 279:22057-22065. 10.1074/jbc.M402828200, 15023995.
36. Giannico G, Mendez M, LaPointe MC. Regulation of the membrane-localized prostaglandin E synthases mPGES-1 and mPGES-2 in cardiac myocytes and fibroblasts. Am J Physiol Heart Circ Physiol 2005, 288:H165-174. 10.1152/ajpheart.00726.2004, 15358613.
37. van Rees BP, Sivula A, Thoren S, Yokozaki H, Jakobsson PJ, Offerhaus GJ, Ristimaki A. Expression of microsomal prostaglandin E synthase-1 in intestinal type gastric adenocarcinoma and in gastric cancer cell lines. Int J Cancer 2003, 107:551-556. 10.1002/ijc.11422, 14520691.
38. Subbaramaiah K, Yoshimatsu K, Scherl E, Das KM, Glazier KD, Golijanin D, Soslow RA, Tanabe T, Naraba H, Dannenberg AJ. Microsomal prostaglandin E synthase-1 is overexpressed in inflammatory bowel disease. Evidence for involvement of the transcription factor Egr-1. J Biol Chem 2004, 279:12647-12658. 10.1074/jbc.M312972200, 14722058.
39. Han R, Tsui S, Smith TJ. Up-regulation of prostaglandin E2 synthesis by interleukin-1beta in human orbital fibroblasts involves coordinate induction of prostaglandin-endoperoxide H synthase-2 and glutathione-dependent prostaglandin E2 synthase expression. J Biol Chem 2002, 277:16355-16364. 10.1074/jbc.M111246200, 11847219.
40. Flavell SJ, Hou TZ, Lax S, Filer AD, Salmon M, Buckley CD. Fibroblasts as novel therapeutic targets in chronic inflammation. Br J Pharmacol 2007, 153(Suppl 1):S241-246. 2268075, 17965753.
41. Heath JK, Atkinson SJ, Hembry RM, Reynolds JJ, Meikle MC. Bacterial antigens induce collagenase and prostaglandin E2 synthesis in human gingival fibroblasts through a primary effect on circulating mononuclear cells. Infect Immun 1987, 55:2148-2154. 260671, 3040590.
42. Kornman KS, Page RC, Tonetti MS. The host response to the microbial challenge in periodontitis: assembling the players. Periodontol 2000 1997, 14:33-53. 10.1111/j.1600-0757.1997.tb00191.x, 9567965.
43. Meikle MC, Hembry RM, Holley J, Horton C, McFarlane CG, Reynolds JJ. Immunolocalization of matrix metalloproteinases and TIMP-1 (tissue inhibitor of metalloproteinases) in human gingival tissues from periodontitis patients. J Periodontal Res 1994, 29:118-126. 10.1111/j.1600-0765.1994.tb01100.x, 8158500.
44. Reynolds JJ, Meikle MC. Mechanisms of connective tissue matrix destruction in periodontitis. Periodontol 2000 1997, 14:144-157. 10.1111/j.1600-0757.1997.tb00195.x, 9567969.
45. Glonek GF, Solomon PJ. Factorial and time course designs for cDNA microarray experiments. Biostatistics 2004, 5:89-111. 10.1093/biostatistics/5.1.89, 14744830.
46. Hacker H, Karin M. Regulation and function of IKK and IKK-related kinases. Sci STKE 2006, 2006:re13. 10.1126/stke.3572006re13, 17047224.
47. Bennett BL, Sasaki DT, Murray BW, O'Leary EC, Sakata ST, Xu W, Leisten JC, Motiwala A, Pierce S, Satoh Y, et al. SP60 an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc Natl Acad Sci USA 0125, 98:13681-13686.
48. Pierce JW, Schoenleber R, Jesmok G, Best J, Moore SA, Collins T, Gerritsen ME. Novel inhibitors of cytokine-induced IkappaBalpha phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo. J Biol Chem 1997, 272:21096-21103. 10.1074/jbc.272.34.21096, 9261113.
49. Swinney DC, Xu YZ, Scarafia LE, Lee I, Mak AY, Gan QF, Ramesha CS, Mulkins MA, Dunn J, So OY, et al. A small molecule ubiquitination inhibitor blocks NF-kappa B-dependent cytokine expression in cells and rats. J Biol Chem 2002, 277:23573-23581. 10.1074/jbc.M200842200, 11950839.
50. Kojima F, Naraba H, Miyamoto S, Beppu M, Aoki H, Kawai S. Membrane-associated prostaglandin E synthase-1 is upregulated by proinflammatory cytokines in chondrocytes from patients with osteoarthritis. Arthritis Res Ther 2004, 6:R355-365. 10.1186/ar1195, 464891, 15225371.
51. Stichtenoth DO, Thoren S, Bian H, Peters-Golden M, Jakobsson PJ, Crofford LJ. Microsomal prostaglandin E synthase is regulated by proinflammatory cytokines and glucocorticoids in primary rheumatoid synovial cells. J Immunol 2001, 167:469-474.
52. Alexander D, Friedrich B, Abruzzese T, Gondolph-Zink B, Wulker N, Aicher WK. The active form of leflunomide, HMR facilitates TNF-alpha and IL-17 induced MMP-1 and MMP-3 expression. Cell Physiol Biochem 2006, 17:69-78. 10.1159/000091465, 16543723.
53. Shen F, Ruddy MJ, Plamondon P, Gaffen SL. Cytokines link osteoblasts and inflammation: microarray analysis of interleukin-17- and TNF-alpha-induced genes in bone cells. J Leukoc Biol 2005, 77:388-399. 10.1189/jlb.0904490, 15591425.
54. Tian B, Nowak DE, Brasier AR. A TNF-induced gene expression program under oscillatory NF-kappaB control. BMC Genomics 2005, 6:137. 10.1186/1471-2164-6-137, 1262712, 16191192.
55. Zer C, Sachs G, Shin JM. Identification of genomic targets downstream of p38 mitogen-activated protein kinase pathway mediating tumor necrosis factor-alpha signaling. Physiol Genomics 2007, 31:343-351. 10.1152/physiolgenomics.00080.2007, 17652167.
56. Zhang HG, Hyde K, Page GP, Brand JP, Zhou J, Yu S, Allison DB, Hsu HC, Mountz JD. Novel tumor necrosis factor alpha-regulated genes in rheumatoid arthritis. Arthritis Rheum 2004, 50:420-431. 10.1002/art.20037, 14872484.
57. Papapanou PN, Abron A, Verbitsky M, Picolos D, Yang J, Qin J, Fine JB, Pavlidis P. Gene expression signatures in chronic and aggressive periodontitis: a pilot study. Eur J Oral Sci 2004, 112:216-223. 10.1111/j.1600-0722.2004.00124.x, 15154918.
58. Beikler T, Peters U, Prior K, Eisenacher M, Flemmig TF. Gene expression in periodontal tissues following treatment. BMC Med Genomics 2008, 1:30. 10.1186/1755-8794-1-30, 2491649, 18606014.
59. Sorensen LK, Havemose-Poulsen A, Sonder SU, Bendtzen K, Holmstrup P. Blood cell gene expression profiling in subjects with aggressive periodontitis and chronic arthritis. J Periodontol 2008, 79:477-485. 10.1902/jop.2008.070309, 18315430.
60. Wang PL, Ohura K, Fujii T, Oido-Mori M, Kowashi Y, Kikuchi M, Suetsugu Y, Tanaka J. DNA microarray analysis of human gingival fibroblasts from healthy and inflammatory gingival tissues. Biochem Biophys Res Commun 2003, 305:970-973. 10.1016/S0006-291X(03)00821-0, 12767925.
61. Vardar-Sengul S, Arora S, Baylas H, Mercola D. Expression profile of human gingival fibroblasts induced by interleukin-1beta reveals central role of nuclear factor-kappa B in stabilizing human gingival fibroblasts during inflammation. J Periodontol 2009, 80:833-849. 10.1902/jop.2009.080483, 19405838.
62. Degousee N, Angoulvant D, Fazel S, Stefanski E, Saha S, Iliescu K, Lindsay TF, Fish JE, Marsden PA, Li RK, et al. c-Jun N-terminal kinase-mediated stabilization of microsomal prostaglandin E2 synthase-1 mRNA regulates delayed microsomal prostaglandin E2 synthase-1 expression and prostaglandin E2 biosynthesis by cardiomyocytes. J Biol Chem 2006, 281:16443-16452. 10.1074/jbc.M602815200, 16627484.
63. Moon Y, Glasgow WC, Eling TE. Curcumin suppresses interleukin 1beta-mediated microsomal prostaglandin E synthase 1 by altering early growth response gene 1 and other signaling pathways. J Pharmacol Exp Ther 2005, 315:788-795. 10.1124/jpet.105.084434, 16081677.
64. Chen CC, Sun YT, Chen JJ, Chang YJ. Tumor necrosis factor-alpha-induced cyclooxygenase-2 expression via sequential activation of ceramide-dependent mitogen-activated protein kinases, and IkappaB kinase 1/2 in human alveolar epithelial cells. Mol Pharmacol 2001, 59:493-500.
65. Wadleigh DJ, Herschman HR. Transcriptional regulation of the cyclooxygenase-2 gene by diverse ligands in murine osteoblasts. Biochem Biophys Res Commun 1999, 264:865-870. 10.1006/bbrc.1999.1606, 10544022.
66. Nieminen R, Lahti A, Jalonen U, Kankaanranta H, Moilanen E. JNK inhibitor SP600125 reduces COX-2 expression by attenuating mRNA in activated murine J774 macrophages. Int Immunopharmacol 2006, 6:987-996. 10.1016/j.intimp.2006.01.009, 16644485.
67. Nieminen R, Leinonen S, Lahti A, Vuolteenaho K, Jalonen U, Kankaanranta H, Goldring MB, Moilanen E. Inhibitors of mitogen-activated protein kinases downregulate COX-2 expression in human chondrocytes. Mediators Inflamm 2005, 2005:249-255. 10.1155/MI.2005.249, 1279039, 16258191.
68. Zhang X, Neufeld AH. Signal transduction pathways for epidermal growth factor stimulated cyclooxygenase-2 induction in astrocytes. Exp Eye Res 2007, 85:280-288. 10.1016/j.exer.2007.05.002, 17604021.
69. Han Z, Boyle DL, Aupperle KR, Bennett B, Manning AM, Firestein GS. Jun N-terminal kinase in rheumatoid arthritis. J Pharmacol Exp Ther 1999, 291:124-130.
70. Mitsuyama K, Suzuki A, Tomiyasu N, Tsuruta O, Kitazaki S, Takeda T, Satoh Y, Bennett BL, Toyonaga A, Sata M. Pro-inflammatory signaling by Jun-N-terminal kinase in inflammatory bowel disease. Int J Mol Med 2006, 17:449-455.
71. Han Z, Boyle DL, Chang L, Bennett B, Karin M, Yang L, Manning AM, Firestein GS. c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis. J Clin Invest 2001, 108:73-81. 209341, 11435459.
72. Han Z, Chang L, Yamanishi Y, Karin M, Firestein GS. Joint damage and inflammation in c-Jun N-terminal kinase 2 knockout mice with passive murine collagen-induced arthritis. Arthritis Rheum 2002, 46:818-823. 10.1002/art.10104, 11920420.
73. Catley MC, Chivers JE, Cambridge LM, Holden N, Slater DM, Staples KJ, Bergmann MW, Loser P, Barnes PJ, Newton R. IL-1beta-dependent activation of NF-kappaB mediates PGE2 release via the expression of cyclooxygenase-2 and microsomal prostaglandin E synthase. FEBS Lett 2003, 547:75-79. 10.1016/S0014-5793(03)00672-0, 12860389.
74. Kuldo JM, Westra J, Asgeirsdottir SA, Kok RJ, Oosterhuis K, Rots MG, Schouten JP, Limburg PC, Molema G. Differential effects of NF-{kappa}B and p38 MAPK inhibitors and combinations thereof on TNF-{alpha}- and IL-1{beta}-induced proinflammatory status of endothelial cells in vitro. Am J Physiol Cell Physiol 2005, 289:C1229-1239. 10.1152/ajpcell.00620.2004, 15972838.
75. Park MH, Song HS, Kim KH, Son DJ, Lee SH, Yoon DY, Kim Y, Park IY, Song S, Hwang BY, et al. Cobrotoxin inhibits NF-kappa B activation and target gene expression through reaction with NF-kappa B signal molecules. Biochemistry 2005, 44:8326-8336. 10.1021/bi050156h, 15938622.
76. Barakat W, Herrmann O, Baumann B, Schwaninger M. NF-kappaB induces PGE2-synthesizing enzymes in neurons. Naunyn Schmiedebergs Arch Pharmacol 2009, 380:153-160. 10.1007/s00210-009-0421-0, 19415240.
77. Casas J, Meana C, Esquinas E, Valdearcos M, Pindado J, Balsinde J, Balboa MA. Requirement of JNK-mediated phosphorylation for translocation of group IVA phospholipase A2 to phagosomes in human macrophages. J Immunol 2009, 183:2767-2774. 10.4049/jimmunol.0901530, 19625654.
78. Yucel-Lindberg T, Ahola H, Carlstedt-Duke J, Modeer T. Induction of Cytosolic Phospholipase A2 mRNA Expression by Interleukin-1β and Tumor Necrosis Factor α in Human Gingival Fibroblasts. Inflammation 2000, 24:207-217.
79. Murakami M, Naraba H, Tanioka T, Semmyo N, Nakatani Y, Kojima F, Ikeda T, Fueki M, Ueno A, Oh S, Kudo I. Regulation of prostaglandin E2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2. J Biol Chem 2000, 275:32783-32792. 10.1074/jbc.M003505200, 10869354.
80. Lindberg J, af Klint E, Ulfgren AK, Stark A, Andersson T, Nilsson P, Klareskog L, Lundeberg J. Variability in synovial inflammation in rheumatoid arthritis investigated by microarray technology. Arthritis Res Ther 2006, 8:R47. 10.1186/ar1903, 1526587, 16507157.
81. KTH microarray core facility homepage. , http://www.ktharray.se
82. Maglott D, Ostell J, Pruitt KD, Tatusova T. Entrez Gene: gene-centered information at NCBI. Nucleic Acids Res 2007, 35:D26-31. 10.1093/nar/gkl993, 1761442, 17148475.
83. R: A language and environment for statistical computing. , http://www.R-project.org
84. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 2004, 5:R80. 10.1186/gb-2004-5-10-r80, 545600, 15461798.
85. Yang YH, Dudoit S, Luu P, Lin DM, Peng V, Ngai J, Speed TP. Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res 2002, 30:e15. 10.1093/nar/30.4.e15, 100354, 11842121.
86. Smyth GK. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 2004, 3:Article3.
87. Reiner A, Yekutieli D, Benjamini Y. Identifying differentially expressed genes using false discovery rate controlling procedures. Bioinformatics 2003, 19:368-375. 10.1093/bioinformatics/btf877, 12584122.
88. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 2000, 25:25-29. 10.1038/75556, 10802651.
89. Falcon S, Gentleman R. Using GOstats to test gene lists for GO term association. Bioinformatics 2007, 23:257-258. 10.1093/bioinformatics/btl567, 17098774.
90. Barrett T, Troup DB, Wilhite SE, Ledoux P, Rudnev D, Evangelista C, Kim IF, Soboleva A, Tomashevsky M, Edgar R. NCBI GEO: mining tens of millions of expression profiles--database and tools update. Nucleic Acids Res 2007, 35:D760-765. 10.1093/nar/gkl887, 1669752, 17099226.
91. Wain HM, Lush M, Ducluzeau F, Povey S. Genew: the human gene nomenclature database. Nucleic Acids Res 2002, 30:169-171. 10.1093/nar/30.1.169, 99058, 11752283.